Literature DB >> 9159376

Premature fat deposition in the salivary glands associated with Sjögren syndrome: MR and CT evidence.

M Izumi1, K Eguchi, H Nakamura, S Nagataki, T Nakamura.   

Abstract

PURPOSE: To investigate abnormal fat deposition in the major salivary glands associated with Sjögren syndrome.
METHODS: We analyzed the fat deposition in the parotid and submandibular glands of 33 patients with Sjögren syndrome by using short-inversion-time inversion recovery (STIR) and fat-saturation MR sequences and CT values.
RESULTS: All three in vivo techniques substantially confirmed premature deposition of fat in the major salivary glands in association with Sjögren syndrome. Furthermore, this change was characteristic of Sjögren syndrome, and the severity of fat deposition correlated well with the impaired rates of salivary flow in these patients.
CONCLUSION: Monitoring of fat deposition might be useful for diagnosing Sjögren syndrome and assessing its progress in patients whose clinical and serologic findings are suggestive of the disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9159376      PMCID: PMC8338096     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  26 in total

Review 1.  Bilateral parotid swelling: a radiological review.

Authors:  A Gadodia; A S Bhalla; R Sharma; A Thakar; R Parshad
Journal:  Dentomaxillofac Radiol       Date:  2011-10       Impact factor: 2.419

2.  MR microscopy of the parotid glands in patients with Sjogren's syndrome: quantitative MR diagnostic criteria.

Authors:  Yukinori Takagi; Misa Sumi; Tadateru Sumi; Yoko Ichikawa; Takashi Nakamura
Journal:  AJNR Am J Neuroradiol       Date:  2005-05       Impact factor: 3.825

3.  Corticosteroid irrigation of parotid gland for treatment of xerostomia in patients with Sjögren's syndrome.

Authors:  M Izumi; K Eguchi; H Nakamura; Y Takagi; Y Kawabe; T Nakamura
Journal:  Ann Rheum Dis       Date:  1998-08       Impact factor: 19.103

4.  Early changes of parotid density and volume predict modifications at the end of therapy and intensity of acute xerostomia.

Authors:  Maria Luisa Belli; Elisa Scalco; Giuseppe Sanguineti; Claudio Fiorino; Sara Broggi; Nicola Dinapoli; Francesco Ricchetti; Vincenzo Valentini; Giovanna Rizzo; Giovanni Mauro Cattaneo
Journal:  Strahlenther Onkol       Date:  2014-04-23       Impact factor: 3.621

5.  Conventional MRI techniques combined with MR sialography on T2-3D-DRIVE in Sjögren syndrome.

Authors:  Yan-De Ren; Xiang-Rong Li; Jing Zhang; Li-Ling Long; Wei-Xiong Li; Yao-Qi Han
Journal:  Int J Clin Exp Med       Date:  2015-03-15

6.  Unilateral agenesis of the parotid gland associated with a pleomorphic adenoma in the ipsilateral buccal space.

Authors:  Byung Hoon Lee
Journal:  Jpn J Radiol       Date:  2010-05-01       Impact factor: 2.374

7.  Estimation of proton density fat fraction of the salivary gland.

Authors:  Toru Chikui; Yasuo Yamashita; Yoshitaka Kise; Tomonori Saito; Kazutoshi Okamura; Kazunori Yoshiura
Journal:  Br J Radiol       Date:  2018-02-06       Impact factor: 3.039

8.  Quantitative MRI analysis of salivary glands in sickle cell disease.

Authors:  J Liao; N Saito; A Ozonoff; H Jara; M Steinberg; O Sakai
Journal:  Dentomaxillofac Radiol       Date:  2012-12       Impact factor: 2.419

9.  Increased expression of cathepsins and obesity-induced proinflammatory cytokines in lacrimal glands of male NOD mouse.

Authors:  Xiaodong Li; Kaijin Wu; Maria Edman; Katja Schenke-Layland; Michelle MacVeigh-Aloni; Srikanth Reddy Janga; Barbara Schulz; Sarah F Hamm-Alvarez
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-12       Impact factor: 4.799

10.  Differential gene expressions in the lacrimal gland during development and onset of keratoconjunctivitis sicca in Sjögren's syndrome (SJS)-like disease of the C57BL/6.NOD-Aec1Aec2 mouse.

Authors:  Cuong Q Nguyen; Ashok Sharma; Jin-Xiong She; Richard A McIndoe; Ammon B Peck
Journal:  Exp Eye Res       Date:  2008-10-18       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.